Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Ruth Oltenfreiter
Profile
Projects
Publications
Activities
Awards & Distinctions
32
Results
2011
Intra-arterial treatment with 90Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital
Bieke Lambert
EMIEL STURM
Jeroen Mertens
Ruth Oltenfreiter
Peter Smeets
Roberto Troisi
Hans Van Vlierberghe
Luc Defreyne
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2011
2010
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells
Christel Vangestel
Marc Peeters
Ruth Oltenfreiter
Yves D'Asseler
Steven Staelens
Magali Van Steenkiste
Jan Philippé
Dennis Kusters
Chris Reutelingsperger
Nancy Van Damme
et al.
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2010
Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent
Magali Van Steenkiste
Ruth Oltenfreiter
Francis Frankenne
Liesbet Vervoort
Erik Maquoi
Agnes Noel
Jean-Michel Foidart
Christophe Van De Wiele
Filip De Vos
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2010
2007
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible arg424 side-chain to selectivity
Anna Tochowicz
Klaus Maskos
Robert Huber
Ruth Oltenfreiter
Vincent Dive
Athanasios Yiotakis
Matteo Zanda
Wolfram Bode
Peter Goettig
A1
Journal Article
in
JOURNAL OF MOLECULAR BIOLOGY
2007
2006
Imaging probes targeting matrix metalloproteinases
Christophe Van De Wiele
Ruth Oltenfreiter
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2006
In vitro and in vivo evaluation of 123I-labeled Monoclonal Antibody against Membrane type-1 matrix metalloproteinase.
Magali Van Steenkiste
Ruth Oltenfreiter
F FRANKENNE
C VAN DE WIELE
F DE VOS
G SLEGERS
C3
Conference
2006
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents
Ruth Oltenfreiter
Ludovicus Staelens
Veerle Kersemans
Bart Cornelissen
F FRANKENNE
JM FOIDART
Christophe Van De Wiele
Guido Slegers
A1
Journal Article
in
APPLIED RADIATION AND ISOTOPES
2006
2005
Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice
Bart Cornelissen
Veerle Kersemans
Lennart Jans
Ludovicus Staelens
Ruth Oltenfreiter
T Thonissen
Eric Achten
Guido Slegers
A1
Journal Article
in
BRITISH JOURNAL OF RADIOLOGY
2005
In vitro and in vivo evaluation of [I-123]-VEGF(165) as a potential tumor marker
Bart Cornelissen
Ruth Oltenfreiter
Veerle Kersemans
Ludovicus Staelens
F FRANKENNE
JM FOIDART
G SLEGERS
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2005
In vivo evaluation of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno [3,4-c]pyridin-5-one: a presumed dopamine D-4 receptor ligand for SPECT studies
Ludovicus Staelens
Ruth Oltenfreiter
Peter Blanckaert
Veerle Kersemans
KATIA VANDENBULCKE
Christophe Van De Wiele
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2005
In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
Ludovicus Staelens
Ruth Oltenfreiter
Filip Dumont
RN WATERHOUSE
K VANDENBULCKE
Peter Blanckaert
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2005
Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyri din-5-one, a potential dopamine D4 ligand for SPECT studies
Ludovicus Staelens
Ruth Oltenfreiter
Bart Cornelissen
Peter Blanckaert
Filip De Vos
Dieter Deforce
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2005
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of Tc-99m labelled epidermal growth factor
Bart Cornelissen
Veerle Kersemans
Ingrid Burvenich
Ruth Oltenfreiter
JL VANDERHEYDEN
O BOERMAN
C VANDEWIELE
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE COMMUNICATIONS
2005
Synthesis, quality control and in vivo evaluation of [I-123] rhTIMP-2, a potential tumour-imaging agent
Ruth Oltenfreiter
Ingrid Burvenich
Ludovicus Staelens
A LEJEUNE
F FRANKENNE
JM FOIDART
Guido Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2005
Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents
Ruth Oltenfreiter
Ludovicus Staelens
Ulrik Hillaert
A HEREMANS
A NOEL
F FRANKENNE
Guido Slegers
A1
Journal Article
in
APPLIED RADIATION AND ISOTOPES
2005
Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents
Ruth Oltenfreiter
Ludovicus Staelens
S LABIED
Veerle Kersemans
F FRANKENNE
A NOEL
Christophe Van De Wiele
Guido Slegers
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2005
2004
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
Bart Cornelissen
Katrien Remaut
Veerle Kersemans
Ruth Oltenfreiter
Ingrid Burvenich
Guido Slegers
C3
Conference
2004
Internalization and cellular processing of radiolabeled monoclonal antibody 14C5
Ingrid Burvenich
Steve Schoonooghe
Ruth Oltenfreiter
Peter Blanckaert
E COENE
Claude Cuvelier
N MERTENS
Guido Slegers
C1
Conference
2004
New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents
Ruth Oltenfreiter
Ludovicus Staelens
A LEJEUNE
Filip Dumont
F FRANKENNE
JM FOIDART
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2004
Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
Ruth Oltenfreiter
Ludovicus Staelens
Ingrid Burvenich
Bart Cornelissen
F Frankenne
JM Foidart
Guido Slegers
C3
Conference
2004
Radiosynthesis and in vivo evaluation of a carboxylic MMP inhibitor as potential SPECT tumour imaging agent
Ruth Oltenfreiter
Ludovicus Staelens
Ingrid Burvenich
F Frankenne
JM Foidart
Guido Slegers
C3
Conference
2004
Synthesis and assessment of [C-11]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography
Jan Courtyn
Bart Cornelissen
Ruth Oltenfreiter
Marleen Vandecapelle
Guido Slegers
Karel Strijckmans
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2004
2003
Biodistribution og 123/125I-VEGF in wild type NMRI and A2058 tumor inoculated athymic mice
Bart Cornelissen
A Janssens
Veerle Kersemans
Ruth Oltenfreiter
Rudi Dierckx
Guido Slegers
C3
Conference
2003
Radiosynthesis and biological activity testing of a potent gelatinase inhibitor, a new potential SPECT tumour imaging agent
Ruth Oltenfreiter
Ludovicus Staelens
A Lejeune
F Olivier
F Frankenne
A Noel
Guido Slegers
C3
Conference
2003
Synthesis and in vivo evaluation in mice and rabbits of [123I]-3-(4-iodobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one as possible agent for imaging of the dopamine D4-receptor
Ludovicus Staelens
Ruth Oltenfreiter
Filip Dumont
Veerle Kersemans
Bart Cornelissen
Guido Slegers
C3
Conference
2003
Synthesis and in vivo evaluation of [123I]-pyrimidine-Org 13063 as potential SPECT radioligand for the 5-HT1A receptor
M Vandecapelle
Filip Dumont
Ruth Oltenfreiter
Kurt Audenaert
D Leysen
Rudi Dierckx
Guido Slegers
C3
Conference
2003
Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
Ludovicus Staelens
Filip Dumont
F DE VOS
Ruth Oltenfreiter
Marleen Vandecapelle
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2003
Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
Ludovicus Staelens
Filip Dumont
F DE VOS
Ruth Oltenfreiter
Marleen Vandecapelle
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2003
2002
Biological activity determination of I-BSP, a potent MMP 2 inhibitor, and its 123I tracer synthesis, World Journal of Nuclear Medicine, 2002, volume 1, supplement 2, S188
Ruth Oltenfreiter
Ludovicus Staelens
A LEJEUNE
F FRANKENNE
Rudi Dierckx
Guido Slegers
C1
Conference
2002
Synthesis and in vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential sigma receptor ligand for SPECT studies
Ludovicus Staelens
Filip Dumont
Filip De Vos
Ruth Oltenfreiter
Ingeborg Goethals
Rudi Dierckx
Guido Slegers
C1
Conference
2002
Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging.
C VAN DE WIELE
Ruth Oltenfreiter
Olivier De Winter
A SIGNORE
Guido Slegers
Rudi Dierckx
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2002
2001
Title: Synthesis, biodistribution and blocking studies in mice of a new 123I-labeled dopamine D3 antagonist Dierckx RA, Slegers G
Ludovicus Staelens
Filip Dumont
F DEVOS
Ruth Oltenfreiter
M VANDECAPELLE
Ingeborg Goethals
Rudi Dierckx
Guido Slegers
C1
Conference
2001